MicroRNA-101 overexpression by IL-6 and TNF-α inhibits cholesterol efflux by suppressing ATP-binding cassette transporter A1 expression.

[1]  K. Croft,et al.  Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis. , 2015, Archives of biochemistry and biophysics.

[2]  X. Ruan,et al.  Effects of miR-33a-5P on ABCA1/G1-Mediated Cholesterol Efflux under Inflammatory Stress in THP-1 Macrophages , 2014, PloS one.

[3]  M. Hayden,et al.  Clinical, Biochemical, and Molecular Characterization of Novel Mutations in ABCA1 in Families with Tangier Disease. , 2014, JIMD reports.

[4]  Junfeng Zhang,et al.  MicroRNA‐101 suppresses liver fibrosis by targeting the TGFβ signalling pathway , 2014, The Journal of pathology.

[5]  Min Zhang,et al.  MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1. , 2014, Atherosclerosis.

[6]  Z. Varghese,et al.  Inflammatory Stress Increases Hepatic CD36 Translational Efficiency via Activation of the mTOR Signalling Pathway , 2014, PloS one.

[7]  Jian Feng,et al.  miR-613 regulates cholesterol efflux by targeting LXRα and ABCA1 in PPARγ activated THP-1 macrophages. , 2014, Biochemical and biophysical research communications.

[8]  Run-lan Cai,et al.  Genkwanin Inhibits Proinflammatory Mediators Mainly through the Regulation of miR-101/MKP-1/MAPK Pathway in LPS-Activated Macrophages , 2014, PloS one.

[9]  Min Zhang,et al.  MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages. , 2014, Atherosclerosis.

[10]  Jing Zhao,et al.  c‐Myc‐mediated epigenetic silencing of MicroRNA‐101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma , 2014, Hepatology.

[11]  Z. Varghese,et al.  Rapamycin-mediated CD36 translational suppression contributes to alleviation of hepatic steatosis. , 2014, Biochemical and biophysical research communications.

[12]  Q. Wang,et al.  An Agomir of miR-144-3p Accelerates Plaque Formation through Impairing Reverse Cholesterol Transport and Promoting Pro-Inflammatory Cytokine Production , 2014, PloS one.

[13]  Hua Gan,et al.  Dialysis Method Alters the Expression of MicroRNA‐33a and Its Target Genes ABCA1, ABCG1 in THP‐1 Macrophages , 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[14]  K. Rayner,et al.  MicroRNA control of high-density lipoprotein metabolism and function. , 2014, Circulation research.

[15]  M. Hayden,et al.  Regulation of ABCA1 Protein Expression and Function in Hepatic and Pancreatic Islet Cells by miR-145 , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[16]  A. Agrawal,et al.  Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis , 2013, Cell Death and Disease.

[17]  M. Odenthal,et al.  1255 miR-101 IN STEATOSIS AND STEATOHEPATITIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) , 2013 .

[18]  J. Zavadil,et al.  Control of Cholesterol Metabolism and Plasma High-Density Lipoprotein Levels by microRNA-144 , 2013, Circulation research.

[19]  W. Lau,et al.  Multi-target lentivirus specific to hepatocellular carcinoma: in vitro and in vivo studies. , 2013, Journal of hepatology.

[20]  Wei Wei,et al.  MiR‐26 controls LXR‐dependent cholesterol efflux by targeting ABCA1 and ARL7 , 2012, FEBS letters.

[21]  Z. Varghese,et al.  Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export , 2012, Journal of gastroenterology and hepatology.

[22]  Yuhua Liu,et al.  Regulation of ABCA1 functions by signaling pathways. , 2012, Biochimica et biophysica acta.

[23]  R. Bittman,et al.  A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol , 2011, Journal of Lipid Research.

[24]  A. Krogh,et al.  microRNA‐101 is a potent inhibitor of autophagy , 2011, The EMBO journal.

[25]  A. Dávalos,et al.  MicroRNA-758 Regulates Cholesterol Efflux Through Posttranscriptional Repression of ATP-Binding Cassette Transporter A1 , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[26]  P. Kris-Etherton,et al.  Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterol. , 2011, Assay and drug development technologies.

[27]  K. Oishi,et al.  PPARα deficiency augments a ketogenic diet-induced circadian PAI-1 expression possibly through PPARγ activation in the liver. , 2010, Biochemical and biophysical research communications.

[28]  Chao-ke Tang,et al.  ATP-Binding Membrane Cassette Transporter A1 (ABCA1): A Possible Link between Inflammation and Reverse Cholesterol Transport , 2010, Molecular medicine.

[29]  Z. Varghese,et al.  Inflammatory cytokines disrupt LDL-receptor feedback regulation and cause statin resistance: a comparative study in human hepatic cells and mesangial cells. , 2007, American journal of physiology. Renal physiology.

[30]  Z. Younossi,et al.  Epidemiology and natural history of NAFLD and NASH. , 2007, Clinics in liver disease.

[31]  Z. Varghese,et al.  Mechanisms of Dysregulation of Low-Density Lipoprotein Receptor Expression in Vascular Smooth Muscle Cells by Inflammatory Cytokines , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[32]  G. Hansson.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[33]  M. Narang,et al.  Reduced histone biotinylation in multiple carboxylase deficiency patients: a nuclear role for holocarboxylase synthetase. , 2003, Human molecular genetics.

[34]  A. Tall,et al.  Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1* , 2000, The Journal of Biological Chemistry.

[35]  T. Langmann,et al.  Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. , 1999, Biochemical and biophysical research communications.

[36]  M. Comalada,et al.  Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis. , 2001, Immunobiology.